Clinical Research Directory
Browse clinical research sites, groups, and studies.
Topical Infliximab in Eyes With Penetrating Keratoplasty
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Summary
Penetrating keratoplasty is a cornea surgery involving several inflammatory complications, of which the most important is glaucoma. Researchers wish to determine whether it is safe to administer infliximab (an anti-inflammatory drug) eye drops after surgery, and whether this eye drop could prevent the occurrence of glaucoma.
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2022-05-01
Completion Date
2028-03-01
Last Updated
2024-08-22
Healthy Volunteers
No
Conditions
Interventions
Topical infliximab
Infliximab eye drops (10mg/ml) administered four (4) times per day for three (3) months.
No topical infliximab
No treatment with infliximab.
Locations (1)
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada